News

VCU Health Will Anchor Redevelopment of Former Richmond Public Safety Building

As reported online by the Richmond Times Dispatch, VCU Health will anchor a new venture by Capital City Partners in downtown Richmond’s Public Safety Building at 500 N. 10th Street.

The conclusion comes four months after the Richmond City Council unanimously agreed to sell the nearly 70-year-old building for $3.5 million.

Capital City Partners said it would begin demolishing the building on the 3-acre property soon to make room for a $325 million, 500,000-square-foot tower development that will be anchored by VCU Health.

In addition to 150,000 square feet of VCU Health office space, the mixed-use development will feature lodging provided by Ronald McDonald House Charities and The Doorways for patients and their families, a VCU Health-operated child care center, 20,000 square feet of ground-level retail space, 90,000 square feet of Class A office space and more than 1,200 parking spaces.

City officials said earlier this year that the Public Safety Building is in poor condition, generates no tax revenue and costs the city about $390,000 annually. The city estimates that needed repairs and maintenance would cost about $21 million.

The city expects the redeveloped property will generate $16.8 million for the city’s general fund over the next decade and nearly $60 million from real estate taxes alone over 25 years.

Capital City Partners has hired the Philadelphia-based architects KieranTimberlake and the local architecture firm SMBW. The contractor for the project is DPR Construction with Canterbury Enterprises.

“As downtown begins to rebound from the challenges of the past year, we know this project will breathe new life into a critical urban core and ensure Richmond’s key healthcare and support institutions are operating at full strength,” Susan Eastridge and Michael Hallmark, the co-developers of the project for Capital City Partners, said in the release.

“We thank the City for their support of this project and we look forward to helping our partners at VCU Health, The Doorways, and Ronald McDonald House Charities expand their services to patients and families.”

Recent News

10/29/2026

ReAlta Life Sciences Launches KnowHIE, a New Online Educational Resource for Families of Babies Diagnosed with Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the launch of KnowHIE.com, a new educational website designed to help families and caregivers better understand neonatal hypoxic ischemic encephalopathy (HIE) …

10/28/2026

Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company developing treatments for serious inflammatory diseases, today announced that it has changed its corporate name to Azora Therapeutics, Inc. The company’s common stock is expected to commence trading on The Nasdaq Capital Market under the new ticker symbol “AZR” on October 29, 2026. Azora has also launched …

10/28/2026

U.S. Bioscience Industry Powers Over $3 Trillion in Economic Output, New Report Finds

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact. The report, “The U.S. Bioscience Economy: Advancing Innovation and Strengthening States and Regions,” examines the industry’s economic footprint through employment, wages, business establishments, university research and development, access …